3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
8
Neoplasms
7
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
5
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Skin Neoplasms
2
Neoplastic Cells, Circulating
2
Lung Diseases
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
von Hippel-Lindau Disease
1
Weight Loss
1
Uterine Cervical Neoplasms
1
Sleep Apnea Syndromes
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Ovarian Insufficiency
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Nervous System Diseases
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Interventions
thymoglobulin
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Etoposide
1
Cytarabine
1
Carmustine
1
Blood Specimen Collection
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Autoimmune Diseases of the Nervous System
×
Blood Specimen Collection
×
Clear all
NCT06002945
2024-12-10
EXPLORE-MG2
Yale University
Active not recruiting
400 enrolled